AjmalicineCAS# 483-04-5 |
- Mayumbine
Catalog No.:BCN5123
CAS No.:25532-45-0
- Akuammigine
Catalog No.:BCN4607
CAS No.:642-17-1
- Tetrahydroalstonine
Catalog No.:BCN4189
CAS No.:6474-90-4
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 483-04-5 | SDF | Download SDF |
PubChem ID | 441975 | Appearance | Yellowish powder |
Formula | C21H24N2O3 | M.Wt | 352.4 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Synonyms | Circolene; Raubasine; Tetrahydroserpentine; Vincaine; Vinceine | ||
Solubility | Soluble in chloroform; sparingly soluble in methanol; insoluble in water | ||
SMILES | CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 | ||
Standard InChIKey | GRTOGORTSDXSFK-XJTZBENFSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Ajmalicine, also known as δ-yohimbine or raubasine, is an antihypertensive drug used in the treatment of high blood pressure. |
Targets | P450 (e.g. CYP17) |
Ajmalicine Dilution Calculator
Ajmalicine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.8377 mL | 14.1884 mL | 28.3768 mL | 56.7537 mL | 70.9421 mL |
5 mM | 0.5675 mL | 2.8377 mL | 5.6754 mL | 11.3507 mL | 14.1884 mL |
10 mM | 0.2838 mL | 1.4188 mL | 2.8377 mL | 5.6754 mL | 7.0942 mL |
50 mM | 0.0568 mL | 0.2838 mL | 0.5675 mL | 1.1351 mL | 1.4188 mL |
100 mM | 0.0284 mL | 0.1419 mL | 0.2838 mL | 0.5675 mL | 0.7094 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 14-Dehydrobrowniine
Catalog No.:BCN8109
CAS No.:4829-56-5
- Tetrahydroamentoflavone
Catalog No.:BCN5571
CAS No.:48236-96-0
- RG 108
Catalog No.:BCC1134
CAS No.:48208-26-0
- Aricine
Catalog No.:BCN5576
CAS No.:482-91-7
- Indigo
Catalog No.:BCN1091
CAS No.:482-89-3
- Dalbergin
Catalog No.:BCN7452
CAS No.:482-83-7
- Nordalbergin
Catalog No.:BCC8344
CAS No.:482-82-6
- Sarpagine
Catalog No.:BCN5575
CAS No.:482-68-8
- Osajin
Catalog No.:BCN4789
CAS No.:482-53-1
- Isobergapten
Catalog No.:BCN2377
CAS No.:482-48-4
- Isoimperatorin
Catalog No.:BCN5897
CAS No.:482-45-1
- Imperatorin
Catalog No.:BCN5574
CAS No.:482-44-0
- Isorauhimbine
Catalog No.:BCN5578
CAS No.:483-09-0
- 9-Hydroxycalabaxanthone hydrate
Catalog No.:BCC5325
CAS No.:483-14-7
- Dihydroberberine
Catalog No.:BCN2573
CAS No.:483-15-8
- Cephaeline
Catalog No.:BCC8143
CAS No.:483-17-0
- (-)-Isocorypalmine
Catalog No.:BCN2723
CAS No.:483-34-1
- Cheilanthifoline
Catalog No.:BCN7827
CAS No.:483-44-3
- Sphondin
Catalog No.:BCN5579
CAS No.:483-66-9
- Toddalolactone
Catalog No.:BCN2393
CAS No.:483-90-9
- Calycanthoside
Catalog No.:BCN5580
CAS No.:483-91-0
- Luvangetin
Catalog No.:BCN7527
CAS No.:483-92-1
- SB-674042
Catalog No.:BCC1931
CAS No.:483313-22-0
- Purmorphamine
Catalog No.:BCC3641
CAS No.:483367-10-8
Effects of beta-cyclodextrin and methyl jasmonate on the production of vindoline, catharanthine, and ajmalicine in Catharanthus roseus cambial meristematic cell cultures.[Pubmed:25981997]
Appl Microbiol Biotechnol. 2015 Sep;99(17):7035-45.
Long-term stable cell growth and production of vindoline, catharanthine, and Ajmalicine of cambial meristematic cells (CMCs) from Catharanthus roseus were observed after 2 years of culture. C. roseus CMCs were treated with beta-cyclodextrin (beta-CD) and methyl jasmonate (MeJA) individually or in combination and were cultured both in conventional Erlenmeyer flasks (100, 250, and 500 mL) and in a 5-L stirred hybrid airlift bioreactor. CMCs of C. roseus cultured in the bioreactor showed higher yields of vindoline, catharanthine, and Ajmalicine than those cultured in flasks. CMCs of C. roseus cultured in the bioreactor and treated with 10 mM beta-CD and 150 muM MeJA gave the highest yields of vindoline (7.45 mg/L), catharanthine (1.76 mg/L), and Ajmalicine (58.98 mg/L), concentrations that were 799, 654, and 426 % higher, respectively, than yields of CMCs cultured in 100-mL flasks without elicitors. Quantitative reverse transcription (RT)-PCR showed that beta-CD and MeJA upregulated transcription levels of genes related to the biosynthesis of terpenoid indole alkaloids (TIAs). This is the first study to report that beta-CD induced the generation of NO, which plays an important role in mediating the production of TIAs in C. roseus CMCs. These results suggest that beta-CD and MeJA can enhance the production of TIAs in CMCs of C. roseus, and thus, CMCs of C. roseus have significant potential to be an industrial platform for production of bioactive alkaloids.